Identification of prostate specific membrane antigen (PSMA) as the target of monoclonal antibody 107-1A4 by proteinchip®; array, surface-enhanced laser desorption/ionization (SELDI) technology

International Journal of Cancer

Volumn 92, Issue 6, 2001, Pages 871-876

  Wang, Shunyou ^a   Diamond, Deborah L ^b   Hass, G Michael ^a   Sokoloff, Roger ^c   Vessella, Robert L ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b CIPHERGEN BIOSYSTEMS INC   (United States)

^c BECKMAN COULTER INC   (United States)

Author keywords

Mass spectrometry; Prostate cancer; Prostate specific membrane antigen

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 107 1A4; PROSTATE SPECIFIC MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DESORPTION; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOLOGICAL PROCEDURES; IONIZATION; MALE; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SURFACE ENHANCED LASER DESORPTION IONIZATION TECHNOLOGY; TECHNOLOGY; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; BINDING, COMPETITIVE; BLOTTING, WESTERN; CARBOXYPEPTIDASES; ELECTROPHORESIS, AGAR GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; LIGANDS; MASS SPECTROMETRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; TRYPSIN; TUMOR CELLS, CULTURED;

EID: 0012472421     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1272     Document Type: Article

References (24)

1. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Human kallikrein 2 (hK2) and prostate specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 1998;35:275-368.
2. Brown LG, Wegner SK, Wang H, et al. A novel monoclonal antibody (107-1A4) with high prostate specificity: generation, characterization of antigen expression, and targeting of human prostate cancer xenografts. Prostate Cancer Prostatic Dis 1998;1:208-15.
3. Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993;7:576-80.
4. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000;21:1164-77.
5. Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987;7:927-36.
6. Grauer LS, Lawler KD, Marignac JL, Kumar A, Goel AS, Wolfert RL. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line. Cancer Res 1998;58:4787-9.
7. Smith-Jones P, Vallabahajosula S, Goldsmith SJ, et al. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Cancer Res 2000;60:5237-43.
8. Gregorakis AK, Holmes EH, Murphy GP. Prostate-specific membrane antigen: current and future utility. Semin Urol Oncol 1998;16:2-12.
9. Wright GL Jr, Cazares LH, Leung S-M, et al. ProteinChip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostate Dis 1999;2:264-76.
10. Xiao Z, Jiang X, Beckett ML, Wright GL Jr. A recombinant prostate specific membrane antigen for development of a novel biochip immunoassay. Protein Express Purification 2000;19:12-21.
11. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-54.
12. Jensen ON, Podtelejnikov AV, Mann M. Identification of the components of simple protein mixtures by high-accuracy peptide mass mapping and database searching. Anal Chem 1997;69:4741-50.
13. Holmes EH, Greene TG, Tino WT, et al. Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients. Prostate Suppl 1996;7:25-9.
14. Scheler C, Lamer S, Pan Z, Li XP, Salnikow J, Jungblut P. Peptide mass fingerprint sequence coverage from differently stained proteins on two-dimensional electrophoresis patterns by matrix assisted laser desorption/ionization-mass spectrometry (MALDI-MS). Electrophoresis 1998;19:918-27.
15. Cohen SL, Chait BT. Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins. Anal Chem 1996;68: 31-7.
16. Krause E, Wenschuh H, Jungblut PR. The dominance of arginine-containing peptides in MALDI-derived tryptic mass fingerprints of proteins. Anal.Chem 1999;71:4160-5.
17. Kussmann M, Lassing U, Sturmer CA, Przybylski M, Roepstorff P. Matrix-assisted laser desorption/ionization mass spectrometric peptide mapping of the neural cell adhesion protein neurolin purified by sodium dodecyl sulfate polyacrylamide gel electrophoresis or acidic precipitation. J Mass Spectrom 1997;32:483-93.
18. Olumee Z, Sadeghi M, Tang X, Vertes A. Amino acid composition and wavelength effects in matrix-assisted laser desorption/ionization. Rapid Commun Mass Spectrom 1995;9:744-52.
19. Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282:1318-21.
20. Hinshelwood J, Spencer DI, Edwards YJ, Perkins SJ. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B. J Mol Biol 1999;294:587-99.
21. Davies H, Lomas L, Austen B. Profiling of amyloid beta peptide variants using SELDI Protein Chip arrays. Biotechniques 1999;27: 1258-61.
22. Beher D, Lewis HD, Clarke E, et al. Poster-240.13: amyloid-B peptide profiles in human Alzheimer's brain and conditioned media of transfected cell lines determined by SELDI-TOF mass spectrometry. Society for Neuroscience Meeting, October 23-28, 1999, Miami Beach, FL. Poster Session: Degenerative disease: Alzheimer's beta amyloid: APP processing II.
23. Frears ER, Stephens DJ, Walters CE, Davies H, Austen BM. The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport 1999; 10:1699-705.
24. Li YM, Lai MT, Xu M, et al. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA 2000;97:6138-43.